Of mechanistical relevance, advanced-stage CRC patients could also be characterized by the significantly decreased expression of the chemokine receptor CXCR3 on the surfaces of circulating CD8+ T cells, while the CXCR3 ligand CXCL10 turned out to be upregulated in the tumor tissue. This evidence concerns the gene CXCL10 and neoplasm.